Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Undergoing CABG/Valve replacement /repair procedure
Exclusion criteria
Exclusion criteria: Patients having contraindications to 1) insertion of TEE 2) weight 3) having organic ds. Of tricuspid valve, tricuspid ring/prosthesis , more than Mild TR , Tricuspid annular calcification 4) Patient on pacemaker 5) having other than sinus heart rhythm 6 ) poor TTE window 7)pericardial disease 8) congenital shunt lesion 9) requiring inotropic/ vasopressor support prior to induction of anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trans-tricuspid early (E) and late (A) diastolic velocities as well as E -wave deceleration time (EDT) will be measured in A4C view by TTE and in Mid-esophageal right ventricular inflow-outflow view, MEB view, DTRVIO view by TEE. Tricuspid annular early (e’) and late (a’) diastolic velocities as well as IVRT will be measured in A4C TTE and in MERVIO view, TGRI view, Deep transgatric right ventricular inflow outflow view by TEETimepoint: single time point at baseline which is immediately after anesthesia induction. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To find out the transesophageal echocardiographic views having best agreement with transthoracic echocardiography for measurement of individual Doppler and Tissue Doppler velocities related to right ventricular diastolic function. 2. To find out the feasibility of measuring the right ventricular diastolic Doppler and Tissue Doppler velocities using different views of transesophageal echocardiography.Timepoint: single time point at baseline which is immediately after anesthesia induction. | — |
Countries
India
Contacts
Pgimer